Press Release

New center will help grow Virginia’s health workforce pipeline and support continuous learning, upskilling and health workforce development.

George Mason University has named Kimberly Davidson as University Ombudsperson, a new position within the university.

Mason Enterprise is partnering with Virginia Bio to establish a new network of life science business mentors to help startups across Virginia launch and scale their ventures.

Fairfax, Va.—George Mason University is pleased to announce that Dr. Sharnnia Artis has been named Vice President for Diversity, Equity and Inclusion and Chief Diversity Officer, effective September 1.

Artis currently serves as Assistant Dean of Access and Inclusion in the Donald Bren School of Information and Computer Sciences and Samueli School of Engineering at the University of California, Irvine, one of the most diverse engineering programs in the nation.

Mason Enterprise at George Mason University has been awarded a GO Virginia grant to expand its network of tech mentors. The funding will support the Innovation Commercialization Assistance Program (ICAP), a program under the Virginia Small Business Development Center (SBDC) Network, doubling its capacity to assist technology and innovation-driven startups across Virginia.

Showcasing a collection of more than 100 native and non-native trees and shrubs, the George Mason University Arboretum earned Level II accreditation from ArbNet, the only international accreditation program specific to arboreta.

As part of an effort to encourage more young women to choose careers in technology, the National Center for Women and Information Technology (NCWIT), George Mason University, Virginia Tech, Virginia Commonwealth University, and Bank of America recognized 157 high school women for their accomplishments and aspirations in computing and technology

Virtual study uses advanced health research technology to examine health, well-being, social and economic effects of COVID-19 on people of all walks of life.

Mason scientists employ a rapid-result, saliva-based test that significantly expands testing capacity, and an antibody test that can track vaccine response.